Monitoring of the prostate tumour cells redox state and real-time proliferation by novel biophysical techniques and fluorescent staining

被引:27
作者
Masarik, Michal [1 ]
Gumulec, Jaromir [1 ]
Hlavna, Marian [1 ,3 ]
Sztalmachova, Marketa [1 ,2 ]
Babula, Petr [3 ]
Raudenska, Martina [1 ]
Pavkova-Goldbergova, Monika [1 ]
Cernei, Natalia [2 ,4 ]
Sochor, Jiri [2 ,4 ]
Zitka, Ondrej [2 ,4 ]
Ruttkay-Nedecky, Branislav [2 ]
Krizkova, Sona [2 ]
Adam, Vojtech [2 ,4 ]
Kizek, Rene [2 ,4 ]
机构
[1] Masaryk Univ, Dept Pathol Physiol, Fac Med, CZ-62500 Brno, Czech Republic
[2] Mendel Univ Brno, Dept Chem & Biochem, Fac Agron, CZ-61300 Brno, Czech Republic
[3] Univ Vet & Pharmaceut Sci, Dept Nat Drugs, Fac Pharm, CZ-61242 Brno, Czech Republic
[4] Brno Univ Technol, Cent European Inst Technol, CZ-61600 Brno, Czech Republic
关键词
OXIDATIVE STRESS; LIQUID-CHROMATOGRAPHY; ACRIDINE-ORANGE; CANCER CELLS; ZINC; METALLOTHIONEIN; TRANSPORTER; METABOLISM; EXPRESSION; SENSOR;
D O I
10.1039/c2ib00157h
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present paper is focused on zinc(II) treatment effects on prostatic cell lines PC-3 (tumour) and PNT1A (non-tumour). Oxidative status of cells was monitored by evaluation of expression of metallothionein (MT) isoforms 1A and 2A at the mRNA and protein level, glutathione (oxidised and reduced), and intracellular zinc(II) after exposition to zinc(II) treatment at concentrations of 0-150 mu M using electrochemical methods, western blotting and fluorescent microscopy. A novel real-time impedance-based growth monitoring system was compared with widely used end-point MTT assay. Impedance-based IC50 for zinc(II) is 55.5 and 150.8 mu M for PC-3 and PNT1A, respectively. MTT-determined IC50 are > 1.3-fold higher. Impedance-based viability correlates with viable count (r > 0.92; p < 0.03), not with MTT. Two-fold lower intracellular zinc(II) in the tumour PC-3 cell line was found. After zinc(II) treatment > 2.6-fold increase of intracellular zinc(II) was observed in non-tumour PNT1A and in tumour PC-3 cells. In PC-3 cells, free and bound zinc(II) levels were enhanced more markedly as compared to PNT1A. PNT1A produced 4.2-fold less MT compared to PC3. PNT1A cells showed a 4.8-fold increase trend (r = 0.94; p = 0.005); PC-3 did show a significant trend at MT1 and MT2 protein levels (r = 0.93; p = 0.02) with nearly ten-fold increase after 100 mu M zinc(II) treatment. In terms of redox state, PNT1A had a predominance of reduced GSH forms (GSH : GSSG ratio > 1), when exposed to zinc(II) compared to PC3, where predominance of oxidised forms remains at all concentrations. IC50 differs significantly when determined by MTT and real-time impedance-based assays due to dependence of impedance on cell morphology and adhesion. When real-time growth monitoring, precise electrochemical methods and fluorescent microscopy are performed together, accurate information for metal fluxes, their buffering by thiol compounds and monitoring of the redox state become a powerful tool for understanding the role of oxidative stress in carcinogenesis.
引用
收藏
页码:672 / 684
页数:13
相关论文
共 54 条
  • [21] The Important Role of the Apoptotic Effects of Zinc in the Development of Cancers
    Franklin, Renty B.
    Costello, Leslie C.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 106 (05) : 750 - 757
  • [22] Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers
    Gumulec, J.
    Masarik, M.
    Krizkova, S.
    Hlavna, M.
    Babula, P.
    Hrabec, R.
    Rovny, A.
    Masarikova, M.
    Sochor, J.
    Adam, V.
    Eckschlager, T.
    Kizek, R.
    [J]. NEOPLASMA, 2012, 59 (02) : 191 - 200
  • [23] Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma
    Gumulec, J.
    Masarik, M.
    Krizkova, S.
    Adam, V.
    Hubalek, J.
    Hrabeta, J.
    Eckschlager, T.
    Stiborova, M.
    Kizek, R.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (33) : 5041 - 5051
  • [25] Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues
    Hasumi, M
    Suzuki, K
    Matsui, H
    Koike, H
    Ito, K
    Yamanaka, H
    [J]. CANCER LETTERS, 2003, 200 (02) : 187 - 195
  • [26] Recent advances in knowledge of zinc nutrition and human health
    Hess, Sonja Y.
    Loennerdal, Bo
    Hotz, Christine
    Rivera, Juan A.
    Brown, Kenneth H.
    [J]. FOOD AND NUTRITION BULLETIN, 2009, 30 (01) : S5 - S11
  • [27] Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation
    Hogstrand, C.
    Kille, P.
    Nicholson, R. I.
    Taylor, K. M.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2009, 15 (03) : 101 - 111
  • [28] A sensor for investigating the interaction between biologically important heavy metals and glutathione
    Huska, D.
    Zitka, O.
    Adam, V.
    Beklova, M.
    Krizkova, S.
    Zeman, L.
    Horna, A.
    Havel, L.
    Zehnalek, J.
    Kizek, R.
    [J]. CZECH JOURNAL OF ANIMAL SCIENCE, 2007, 52 (02) : 37 - 43
  • [29] Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction
    Iguchi, K
    Hamatake, M
    Ishida, R
    Usami, Y
    Adachi, T
    Yamamoto, H
    Koshida, K
    Uchibayashi, T
    Hirano, K
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 253 (03): : 766 - 770
  • [30] Overview of mammalian zinc transporters
    Kambe, T
    Yamaguchi-Iwai, Y
    Sasaki, R
    Nagao, M
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (01) : 49 - 68